nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—CYP1A2—chronic obstructive pulmonary disease	0.293	1	CbGaD
Buprenorphine—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.06	0.125	CbGbCtD
Buprenorphine—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.06	0.125	CbGbCtD
Buprenorphine—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0455	0.0949	CbGbCtD
Buprenorphine—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0267	0.0557	CbGbCtD
Buprenorphine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0248	0.0518	CbGbCtD
Buprenorphine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0248	0.0518	CbGbCtD
Buprenorphine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0224	0.0468	CbGbCtD
Buprenorphine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0206	0.0431	CbGbCtD
Buprenorphine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0206	0.0431	CbGbCtD
Buprenorphine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0195	0.0407	CbGbCtD
Buprenorphine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0189	0.0394	CbGbCtD
Buprenorphine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0189	0.0394	CbGbCtD
Buprenorphine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0168	0.0351	CbGbCtD
Buprenorphine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0158	0.0331	CbGbCtD
Buprenorphine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0156	0.0326	CbGbCtD
Buprenorphine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0107	0.0223	CbGbCtD
Buprenorphine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0104	0.0218	CbGbCtD
Buprenorphine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0102	0.0213	CbGbCtD
Buprenorphine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0091	0.019	CbGbCtD
Buprenorphine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00891	0.0186	CbGbCtD
Buprenorphine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00841	0.0176	CbGbCtD
Buprenorphine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00534	0.0111	CbGbCtD
Buprenorphine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00504	0.0105	CbGbCtD
Buprenorphine—Naloxone—TLR4—chronic obstructive pulmonary disease	0.00248	0.889	CrCbGaD
Buprenorphine—Naloxone—ALB—chronic obstructive pulmonary disease	0.00031	0.111	CrCbGaD
Buprenorphine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000177	0.00116	CcSEcCtD
Buprenorphine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00116	CcSEcCtD
Buprenorphine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000176	0.00115	CcSEcCtD
Buprenorphine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.00115	CcSEcCtD
Buprenorphine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00114	CcSEcCtD
Buprenorphine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00114	CcSEcCtD
Buprenorphine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00114	CcSEcCtD
Buprenorphine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000175	0.00114	CcSEcCtD
Buprenorphine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00114	CcSEcCtD
Buprenorphine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000174	0.00113	CcSEcCtD
Buprenorphine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.00113	CcSEcCtD
Buprenorphine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000174	0.00113	CcSEcCtD
Buprenorphine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000174	0.00113	CcSEcCtD
Buprenorphine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000174	0.00113	CcSEcCtD
Buprenorphine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.00113	CcSEcCtD
Buprenorphine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000173	0.00113	CcSEcCtD
Buprenorphine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00113	CcSEcCtD
Buprenorphine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000173	0.00113	CcSEcCtD
Buprenorphine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00112	CcSEcCtD
Buprenorphine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000172	0.00112	CcSEcCtD
Buprenorphine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.00112	CcSEcCtD
Buprenorphine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000172	0.00112	CcSEcCtD
Buprenorphine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00111	CcSEcCtD
Buprenorphine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00017	0.00111	CcSEcCtD
Buprenorphine—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.00111	CcSEcCtD
Buprenorphine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000169	0.0011	CcSEcCtD
Buprenorphine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000168	0.0011	CcSEcCtD
Buprenorphine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00109	CcSEcCtD
Buprenorphine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00109	CcSEcCtD
Buprenorphine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00109	CcSEcCtD
Buprenorphine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000166	0.00108	CcSEcCtD
Buprenorphine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.00108	CcSEcCtD
Buprenorphine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000165	0.00108	CcSEcCtD
Buprenorphine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00107	CcSEcCtD
Buprenorphine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00107	CcSEcCtD
Buprenorphine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00107	CcSEcCtD
Buprenorphine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00106	CcSEcCtD
Buprenorphine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000162	0.00106	CcSEcCtD
Buprenorphine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00106	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00105	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00105	CcSEcCtD
Buprenorphine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00105	CcSEcCtD
Buprenorphine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00105	CcSEcCtD
Buprenorphine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00104	CcSEcCtD
Buprenorphine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00016	0.00104	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000158	0.00103	CcSEcCtD
Buprenorphine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00103	CcSEcCtD
Buprenorphine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00103	CcSEcCtD
Buprenorphine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00103	CcSEcCtD
Buprenorphine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00103	CcSEcCtD
Buprenorphine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000157	0.00102	CcSEcCtD
Buprenorphine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00102	CcSEcCtD
Buprenorphine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00102	CcSEcCtD
Buprenorphine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00102	CcSEcCtD
Buprenorphine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000156	0.00102	CcSEcCtD
Buprenorphine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000156	0.00101	CcSEcCtD
Buprenorphine—Injury—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00101	CcSEcCtD
Buprenorphine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00101	CcSEcCtD
Buprenorphine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000154	0.00101	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000153	0.000999	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.000999	CcSEcCtD
Buprenorphine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000153	0.000997	CcSEcCtD
Buprenorphine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000153	0.000997	CcSEcCtD
Buprenorphine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.000997	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.000995	CcSEcCtD
Buprenorphine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000152	0.000989	CcSEcCtD
Buprenorphine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.000989	CcSEcCtD
Buprenorphine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000152	0.000989	CcSEcCtD
Buprenorphine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.000989	CcSEcCtD
Buprenorphine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000988	CcSEcCtD
Buprenorphine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000981	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00015	0.000978	CcSEcCtD
Buprenorphine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00015	0.000977	CcSEcCtD
Buprenorphine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000974	CcSEcCtD
Buprenorphine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000971	CcSEcCtD
Buprenorphine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000149	0.000969	CcSEcCtD
Buprenorphine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000148	0.000966	CcSEcCtD
Buprenorphine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.000961	CcSEcCtD
Buprenorphine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000147	0.000958	CcSEcCtD
Buprenorphine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000147	0.000957	CcSEcCtD
Buprenorphine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.000955	CcSEcCtD
Buprenorphine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000146	0.000953	CcSEcCtD
Buprenorphine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.000953	CcSEcCtD
Buprenorphine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000146	0.000952	CcSEcCtD
Buprenorphine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00095	CcSEcCtD
Buprenorphine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000145	0.000948	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.000946	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000145	0.000946	CcSEcCtD
Buprenorphine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000945	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.000943	CcSEcCtD
Buprenorphine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.000942	CcSEcCtD
Buprenorphine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.000934	CcSEcCtD
Buprenorphine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.000934	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000142	0.000927	CcSEcCtD
Buprenorphine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000926	CcSEcCtD
Buprenorphine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000141	0.000919	CcSEcCtD
Buprenorphine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.000919	CcSEcCtD
Buprenorphine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00014	0.000914	CcSEcCtD
Buprenorphine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.000914	CcSEcCtD
Buprenorphine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00014	0.000914	CcSEcCtD
Buprenorphine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.000914	CcSEcCtD
Buprenorphine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000912	CcSEcCtD
Buprenorphine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00014	0.000911	CcSEcCtD
Buprenorphine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000905	CcSEcCtD
Buprenorphine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000139	0.000904	CcSEcCtD
Buprenorphine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000139	0.000903	CcSEcCtD
Buprenorphine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000139	0.000903	CcSEcCtD
Buprenorphine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000138	0.0009	CcSEcCtD
Buprenorphine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.0009	CcSEcCtD
Buprenorphine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000138	0.000898	CcSEcCtD
Buprenorphine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.000898	CcSEcCtD
Buprenorphine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000137	0.000896	CcSEcCtD
Buprenorphine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000137	0.000896	CcSEcCtD
Buprenorphine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000894	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.000893	CcSEcCtD
Buprenorphine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000877	CcSEcCtD
Buprenorphine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.000868	CcSEcCtD
Buprenorphine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000863	CcSEcCtD
Buprenorphine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000863	CcSEcCtD
Buprenorphine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.000852	CcSEcCtD
Buprenorphine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000131	0.000852	CcSEcCtD
Buprenorphine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000131	0.000851	CcSEcCtD
Buprenorphine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.00085	CcSEcCtD
Buprenorphine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000849	CcSEcCtD
Buprenorphine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000128	0.000835	CcSEcCtD
Buprenorphine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.00083	CcSEcCtD
Buprenorphine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000127	0.00083	CcSEcCtD
Buprenorphine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.000818	CcSEcCtD
Buprenorphine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000126	0.000818	CcSEcCtD
Buprenorphine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000817	CcSEcCtD
Buprenorphine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000817	CcSEcCtD
Buprenorphine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000125	0.000813	CcSEcCtD
Buprenorphine—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000806	CcSEcCtD
Buprenorphine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.000805	CcSEcCtD
Buprenorphine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000123	0.000802	CcSEcCtD
Buprenorphine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.000791	CcSEcCtD
Buprenorphine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000121	0.000791	CcSEcCtD
Buprenorphine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000784	CcSEcCtD
Buprenorphine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000119	0.000775	CcSEcCtD
Buprenorphine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.000773	CcSEcCtD
Buprenorphine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000768	CcSEcCtD
Buprenorphine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.000765	CcSEcCtD
Buprenorphine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000117	0.000765	CcSEcCtD
Buprenorphine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000749	CcSEcCtD
Buprenorphine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000747	CcSEcCtD
Buprenorphine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000736	CcSEcCtD
Buprenorphine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000736	CcSEcCtD
Buprenorphine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.000729	CcSEcCtD
Buprenorphine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000112	0.000729	CcSEcCtD
Buprenorphine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000112	0.000729	CcSEcCtD
Buprenorphine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.000729	CcSEcCtD
Buprenorphine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000725	CcSEcCtD
Buprenorphine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000725	CcSEcCtD
Buprenorphine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000724	CcSEcCtD
Buprenorphine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000723	CcSEcCtD
Buprenorphine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000722	CcSEcCtD
Buprenorphine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000111	0.00072	CcSEcCtD
Buprenorphine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000714	CcSEcCtD
Buprenorphine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000109	0.000714	CcSEcCtD
Buprenorphine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000712	CcSEcCtD
Buprenorphine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000712	CcSEcCtD
Buprenorphine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000109	0.00071	CcSEcCtD
Buprenorphine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000701	CcSEcCtD
Buprenorphine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000694	CcSEcCtD
Buprenorphine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000692	CcSEcCtD
Buprenorphine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.00069	CcSEcCtD
Buprenorphine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000689	CcSEcCtD
Buprenorphine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000688	CcSEcCtD
Buprenorphine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000688	CcSEcCtD
Buprenorphine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.000687	CcSEcCtD
Buprenorphine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000105	0.000687	CcSEcCtD
Buprenorphine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000684	CcSEcCtD
Buprenorphine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000675	CcSEcCtD
Buprenorphine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000103	0.000673	CcSEcCtD
Buprenorphine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000665	CcSEcCtD
Buprenorphine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000663	CcSEcCtD
Buprenorphine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000652	CcSEcCtD
Buprenorphine—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.95e-05	0.000649	CcSEcCtD
Buprenorphine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	9.91e-05	0.000646	CcSEcCtD
Buprenorphine—Hallucination—Prednisone—chronic obstructive pulmonary disease	9.78e-05	0.000638	CcSEcCtD
Buprenorphine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	9.66e-05	0.00063	CcSEcCtD
Buprenorphine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	9.61e-05	0.000626	CcSEcCtD
Buprenorphine—Oedema—Prednisolone—chronic obstructive pulmonary disease	9.61e-05	0.000626	CcSEcCtD
Buprenorphine—Shock—Prednisolone—chronic obstructive pulmonary disease	9.46e-05	0.000616	CcSEcCtD
Buprenorphine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	9.38e-05	0.000611	CcSEcCtD
Buprenorphine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	9.29e-05	0.000606	CcSEcCtD
Buprenorphine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	9.19e-05	0.000599	CcSEcCtD
Buprenorphine—Flushing—Prednisone—chronic obstructive pulmonary disease	9.12e-05	0.000595	CcSEcCtD
Buprenorphine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.000581	CcSEcCtD
Buprenorphine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	8.88e-05	0.000579	CcSEcCtD
Buprenorphine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	8.69e-05	0.000567	CcSEcCtD
Buprenorphine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	8.63e-05	0.000563	CcSEcCtD
Buprenorphine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	8.61e-05	0.000561	CcSEcCtD
Buprenorphine—Erythema—Prednisone—chronic obstructive pulmonary disease	8.56e-05	0.000558	CcSEcCtD
Buprenorphine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	8.56e-05	0.000558	CcSEcCtD
Buprenorphine—Pain—Prednisolone—chronic obstructive pulmonary disease	8.22e-05	0.000536	CcSEcCtD
Buprenorphine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	8.06e-05	0.000526	CcSEcCtD
Buprenorphine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	7.94e-05	0.000518	CcSEcCtD
Buprenorphine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.92e-05	0.000516	CcSEcCtD
Buprenorphine—Agitation—Prednisone—chronic obstructive pulmonary disease	7.86e-05	0.000513	CcSEcCtD
Buprenorphine—Angioedema—Prednisone—chronic obstructive pulmonary disease	7.82e-05	0.00051	CcSEcCtD
Buprenorphine—Malaise—Prednisone—chronic obstructive pulmonary disease	7.72e-05	0.000503	CcSEcCtD
Buprenorphine—Vertigo—Prednisone—chronic obstructive pulmonary disease	7.69e-05	0.000501	CcSEcCtD
Buprenorphine—Syncope—Prednisone—chronic obstructive pulmonary disease	7.67e-05	0.0005	CcSEcCtD
Buprenorphine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.64e-05	0.000498	CcSEcCtD
Buprenorphine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	7.52e-05	0.00049	CcSEcCtD
Buprenorphine—Convulsion—Prednisone—chronic obstructive pulmonary disease	7.41e-05	0.000483	CcSEcCtD
Buprenorphine—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.39e-05	0.000482	CcSEcCtD
Buprenorphine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.29e-05	0.000475	CcSEcCtD
Buprenorphine—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.29e-05	0.000475	CcSEcCtD
Buprenorphine—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.26e-05	0.000473	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.000472	CcSEcCtD
Buprenorphine—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.2e-05	0.000469	CcSEcCtD
Buprenorphine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.08e-05	0.000462	CcSEcCtD
Buprenorphine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.98e-05	0.000455	CcSEcCtD
Buprenorphine—Oedema—Prednisone—chronic obstructive pulmonary disease	6.98e-05	0.000455	CcSEcCtD
Buprenorphine—Infection—Prednisone—chronic obstructive pulmonary disease	6.94e-05	0.000452	CcSEcCtD
Buprenorphine—Shock—Prednisone—chronic obstructive pulmonary disease	6.87e-05	0.000448	CcSEcCtD
Buprenorphine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.000446	CcSEcCtD
Buprenorphine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.82e-05	0.000444	CcSEcCtD
Buprenorphine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	6.78e-05	0.000442	CcSEcCtD
Buprenorphine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.75e-05	0.00044	CcSEcCtD
Buprenorphine—Anorexia—Prednisone—chronic obstructive pulmonary disease	6.66e-05	0.000434	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.36e-05	0.000415	CcSEcCtD
Buprenorphine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.36e-05	0.000414	CcSEcCtD
Buprenorphine—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.32e-05	0.000412	CcSEcCtD
Buprenorphine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.27e-05	0.000409	CcSEcCtD
Buprenorphine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.15e-05	0.000401	CcSEcCtD
Buprenorphine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.000396	CcSEcCtD
Buprenorphine—Rash—Prednisolone—chronic obstructive pulmonary disease	6.06e-05	0.000395	CcSEcCtD
Buprenorphine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.05e-05	0.000395	CcSEcCtD
Buprenorphine—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.02e-05	0.000392	CcSEcCtD
Buprenorphine—Headache—Prednisolone—chronic obstructive pulmonary disease	6.02e-05	0.000392	CcSEcCtD
Buprenorphine—Constipation—Prednisone—chronic obstructive pulmonary disease	5.97e-05	0.000389	CcSEcCtD
Buprenorphine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.76e-05	0.000375	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.71e-05	0.000372	CcSEcCtD
Buprenorphine—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.71e-05	0.000372	CcSEcCtD
Buprenorphine—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.55e-05	0.000362	CcSEcCtD
Buprenorphine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.52e-05	0.00036	CcSEcCtD
Buprenorphine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.52e-05	0.00036	CcSEcCtD
Buprenorphine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.15e-05	0.000335	CcSEcCtD
Buprenorphine—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.01e-05	0.000327	CcSEcCtD
Buprenorphine—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.94e-05	0.000322	CcSEcCtD
Buprenorphine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.78e-05	0.000311	CcSEcCtD
Buprenorphine—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.62e-05	0.000301	CcSEcCtD
Buprenorphine—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.44e-05	0.000289	CcSEcCtD
Buprenorphine—Rash—Prednisone—chronic obstructive pulmonary disease	4.4e-05	0.000287	CcSEcCtD
Buprenorphine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.4e-05	0.000287	CcSEcCtD
Buprenorphine—Headache—Prednisone—chronic obstructive pulmonary disease	4.38e-05	0.000285	CcSEcCtD
Buprenorphine—Nausea—Prednisone—chronic obstructive pulmonary disease	4.15e-05	0.00027	CcSEcCtD
Buprenorphine—OPRK1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.04e-05	0.000284	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.03e-05	0.000283	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2e-05	0.000279	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2e-05	0.000279	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2e-05	0.000279	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.98e-05	0.000277	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.98e-05	0.000276	CbGpPWpGaD
Buprenorphine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.97e-05	0.000275	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.97e-05	0.000274	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.97e-05	0.000274	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.93e-05	0.000269	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.91e-05	0.000266	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.88e-05	0.000263	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.88e-05	0.000262	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.86e-05	0.000259	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.85e-05	0.000258	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.85e-05	0.000257	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.81e-05	0.000252	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.8e-05	0.000251	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.79e-05	0.00025	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.79e-05	0.000249	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.77e-05	0.000247	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.76e-05	0.000245	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.76e-05	0.000245	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.74e-05	0.000242	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.73e-05	0.000242	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.73e-05	0.000241	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.73e-05	0.000241	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.72e-05	0.00024	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.72e-05	0.00024	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.71e-05	0.000239	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.7e-05	0.000237	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.68e-05	0.000235	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.68e-05	0.000235	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.68e-05	0.000234	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.66e-05	0.000232	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.66e-05	0.000232	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.63e-05	0.000227	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.63e-05	0.000227	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.63e-05	0.000227	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.61e-05	0.000225	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.61e-05	0.000225	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.61e-05	0.000224	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.6e-05	0.000223	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.6e-05	0.000223	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.59e-05	0.000222	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.58e-05	0.000221	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.57e-05	0.000219	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.56e-05	0.000218	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.56e-05	0.000218	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.54e-05	0.000215	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.53e-05	0.000214	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.53e-05	0.000213	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.53e-05	0.000213	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.52e-05	0.000212	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.51e-05	0.000211	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.49e-05	0.000208	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.49e-05	0.000207	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.47e-05	0.000206	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.46e-05	0.000204	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.46e-05	0.000204	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.43e-05	0.0002	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.43e-05	0.000199	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.42e-05	0.000199	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.41e-05	0.000197	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.4e-05	0.000195	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.4e-05	0.000195	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.4e-05	0.000195	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.39e-05	0.000194	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.39e-05	0.000194	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.38e-05	0.000193	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.38e-05	0.000192	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.37e-05	0.000191	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.34e-05	0.000187	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.34e-05	0.000187	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.34e-05	0.000187	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.32e-05	0.000184	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.3e-05	0.000182	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.29e-05	0.000181	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.28e-05	0.000179	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.28e-05	0.000179	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.28e-05	0.000178	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.28e-05	0.000178	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.28e-05	0.000178	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.26e-05	0.000175	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.26e-05	0.000175	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.25e-05	0.000174	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.25e-05	0.000174	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.25e-05	0.000174	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.22e-05	0.00017	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.21e-05	0.000169	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.2e-05	0.000168	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.2e-05	0.000167	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.18e-05	0.000165	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.18e-05	0.000164	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.17e-05	0.000163	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.000162	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.16e-05	0.000162	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.16e-05	0.000162	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.15e-05	0.000161	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.14e-05	0.000159	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.13e-05	0.000158	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.11e-05	0.000154	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.1e-05	0.000153	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.09e-05	0.000152	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.08e-05	0.000151	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.07e-05	0.00015	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.07e-05	0.000149	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.07e-05	0.000149	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.06e-05	0.000148	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.06e-05	0.000147	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.06e-05	0.000147	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.06e-05	0.000147	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.05e-05	0.000147	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.04e-05	0.000145	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—ALB—chronic obstructive pulmonary disease	1.04e-05	0.000145	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.04e-05	0.000145	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.03e-05	0.000143	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.02e-05	0.000142	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.02e-05	0.000142	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.01e-05	0.000141	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.01e-05	0.000141	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—NOS3—chronic obstructive pulmonary disease	9.95e-06	0.000139	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.94e-06	0.000139	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.83e-06	0.000137	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.72e-06	0.000136	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.65e-06	0.000135	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.63e-06	0.000134	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.59e-06	0.000134	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.52e-06	0.000133	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	9.51e-06	0.000133	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.41e-06	0.000131	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.32e-06	0.00013	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	9.3e-06	0.00013	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.23e-06	0.000129	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.19e-06	0.000128	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.09e-06	0.000127	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	9.08e-06	0.000127	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.76e-06	0.000122	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.68e-06	0.000121	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.67e-06	0.000121	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.66e-06	0.000121	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.58e-06	0.00012	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.58e-06	0.00012	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	8.56e-06	0.000119	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	8.49e-06	0.000118	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	8.48e-06	0.000118	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.44e-06	0.000118	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.35e-06	0.000116	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.32e-06	0.000116	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.29e-06	0.000116	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ALB—chronic obstructive pulmonary disease	8.22e-06	0.000115	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.05e-06	0.000112	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.97e-06	0.000111	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.91e-06	0.00011	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—NOS3—chronic obstructive pulmonary disease	7.86e-06	0.00011	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.82e-06	0.000109	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	7.81e-06	0.000109	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.75e-06	0.000108	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	7.74e-06	0.000108	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.7e-06	0.000107	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.63e-06	0.000107	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.61e-06	0.000106	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.35e-06	0.000103	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.33e-06	0.000102	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.32e-06	0.000102	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.31e-06	0.000102	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	7.25e-06	0.000101	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.21e-06	0.000101	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.19e-06	0.0001	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.13e-06	9.95e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.06e-06	9.84e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	6.97e-06	9.73e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.96e-06	9.71e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	6.91e-06	9.64e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.76e-06	9.43e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.75e-06	9.41e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.73e-06	9.39e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.72e-06	9.37e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	6.67e-06	9.31e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	6.62e-06	9.23e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	6.61e-06	9.22e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.52e-06	9.1e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.43e-06	8.98e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.43e-06	8.97e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.42e-06	8.95e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.37e-06	8.88e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.37e-06	8.88e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	6.34e-06	8.84e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.28e-06	8.76e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.25e-06	8.72e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.1e-06	8.51e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	6.06e-06	8.45e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6e-06	8.37e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	6e-06	8.36e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.95e-06	8.3e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.92e-06	8.26e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.87e-06	8.18e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.85e-06	8.16e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.74e-06	8e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.7e-06	7.95e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.68e-06	7.93e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.66e-06	7.9e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.62e-06	7.85e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.59e-06	7.8e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.55e-06	7.74e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.51e-06	7.69e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.48e-06	7.64e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.47e-06	7.63e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.42e-06	7.56e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.23e-06	7.29e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.18e-06	7.23e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.16e-06	7.2e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.11e-06	7.12e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.08e-06	7.09e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.03e-06	7.02e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.01e-06	6.99e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	5e-06	6.97e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.93e-06	6.88e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	4.78e-06	6.67e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.72e-06	6.59e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.7e-06	6.56e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.67e-06	6.52e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.63e-06	6.46e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.43e-06	6.18e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	4.33e-06	6.04e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.32e-06	6.03e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.25e-06	5.93e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.17e-06	5.81e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.14e-06	5.78e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	4.14e-06	5.78e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.92e-06	5.47e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.87e-06	5.4e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.86e-06	5.39e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.79e-06	5.29e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.77e-06	5.26e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.7e-06	5.15e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.61e-06	5.03e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.61e-06	5.03e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.55e-06	4.96e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.52e-06	4.91e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.5e-06	4.88e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.42e-06	4.77e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.4e-06	4.74e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.37e-06	4.7e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.2e-06	4.47e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.01e-06	4.2e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.88e-06	4.02e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.32e-06	3.24e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.22e-06	3.1e-05	CbGpPWpGaD
